Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12 USD | -18.09% | +1.97% | -53.81% |
03/07 | Top Decliners | MT |
03/07 | UBS Adjusts Price Target on Walgreens Boots Alliance to $12 From $17, Maintains Neutral Rating | MT |
Chart calendar Walgreens Boots Alliance, Inc.
Upcoming events on Walgreens Boots Alliance, Inc.
Past events on Walgreens Boots Alliance, Inc.
27/06/2024 06:00 pm | Q3 2024 Earnings Call |
27/06/2024 04:30 pm | Q3 2024 Earnings Release |
20/05/2024 | Détachement de |
28/03/2024 06:00 pm | Q2 2024 Earnings Call |
28/03/2024 04:30 pm | Q2 2024 Earnings Release |
04/03/2024 07:40 pm | TD Cowen Health Care Conference |
16/02/2024 | Détachement de |
25/01/2024 07:00 pm | Annual General Meeting |
08/01/2024 09:45 pm | JPMorgan Healthcare Conference |
04/01/2024 07:00 pm | Q1 2024 Earnings Call |
04/01/2024 05:30 pm | Q1 2024 Earnings Release |
13/11/2023 | Détachement de |
12/10/2023 06:00 pm | Q4 2023 Earnings Call |
12/10/2023 04:30 pm | Q4 2023 Earnings Release |
22/09/2023 12:30 am | TD Cowen FutureHealth Conference |
18/08/2023 | Détachement de |
27/06/2023 06:00 pm | Q3 2023 Earnings Call |
27/06/2023 04:30 pm | Q3 2023 Earnings Release |
18/05/2023 | Détachement de |
28/03/2023 06:00 pm | Q2 2023 Earnings Call |
Past dividends on Walgreens Boots Alliance, Inc.
20/05/2024 | Quarterly 0.25 USD |
16/02/2024 | Quarterly 0.25 USD |
13/11/2023 | Quarterly 0.48 USD |
18/08/2023 | Quarterly 0.48 USD |
18/05/2023 | Quarterly 0.48 USD |
15/02/2023 | Quarterly 0.48 USD |
14/11/2022 | Quarterly 0.48 USD |
18/08/2022 | Quarterly 0.48 USD |
19/05/2022 | Quarterly 0.4775 USD |
17/02/2022 | Quarterly 0.4775 USD |
Annual results
Fiscal Period | August | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 136 866 136 837 0.02% | 139 537 139 176 0.26% | 132 509 131 804 0.54% | 132 703 132 452 0.19% | 139 081 138 463 0.45% | 145 646 |
EBITDA Million USD | Released Forecast Spread | 8 413 8 484 -0.84% | 7 138 6 735 5.98% | 6 567 6 443 1.93% | 6 268 6 323 -0.88% | 5 002 5 408 -7.51% | 4 430 |
EBIT Million USD | Released Forecast Spread | 6 942 7 049 -1.51% | 5 211 5 173 0.74% | 5 117 4 972 2.92% | 5 133 5 157 -0.47% | 3 871 3 940 -1.76% | 2 668 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4 527 4 965 -8.81% | 743 730 1.72% | 1 995 2 323 -14.13% | 3 985 5 366 -25.74% | -5 419 -4 794 -13.04% | -13 328 |
Net income Million USD | Released Forecast Spread | 3 982 4 404 -9.58% | 456 894 -48.98% | 2 542 2 604 -2.38% | 4 337 5 139 -15.6% | -3 080 -2 563 -20.17% | -6 937 |
EPS USD | Released Forecast Spread | 4,31 4,69 -8.1% | 0,52 0,72 -27.6% | 2,93 2,95 -0.79% | 5,01 5,93 -15.47% | -3,57 -2,97 -20.21% | -8,30 |
Announcement Date | 28/10/19 | 15/10/20 | 14/10/21 | 13/10/22 | 12/10/23 | - |
Quarterly results
Fiscal Period | August | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 32 597 32 118 1.49% | 32 449 32 171 0.87% | 33 382 32 970 1.25% | 34 862 33 564 3.87% | 35 415 34 124 3.78% | 35 422 34 798 1.79% | 36 707 35 036 4.77% | 37 052 35 831 3.41% | 36 351 35 930 1.17% | 35 608 | 37 198 | 37 444 | 36 873 | 36 359 |
EBITDA Million USD | Released Forecast Spread | 1 232 1 273 -3.2% | 993 1 043 -4.79% | 1 510 1 554 -2.84% | 1 774 1 533 15.72% | 1 556 1 551 0.31% | 1 013 1 188 -14.77% | 1 028 989 3.99% | 1 244 1 229 1.25% | 1 220 1 145 6.56% | 898 | 1 128 | 1 227 | 1 101 | 1 049 |
EBIT Million USD | Released Forecast Spread | 955 931 2.59% | 744 769 -3.2% | 1 014 1 179 -14.01% | 1 215 1 248 -2.64% | 959 1 182 -18.88% | 683 756 -9.66% | 687 672 2.25% | 900 841 6.95% | 613 737 -16.84% | 434 | 579 | 717 | 603 | 506 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,0 727 -102.48% | -758 540 -240.37% | -5 270 824 -739.95% | 607 710 -14.46% | -382 765 -149.92% | -375 344 -209.13% | -358 447 -180.09% | -13 114 261 -5130.72% | 251 322 -21.94% | -51,8 | 179 | 357 | 91,4 | 35,5 |
Net income Million USD | Released Forecast Spread | 289 586 -50.64% | -415 440 -194.42% | -3 721 801 -564.45% | 703 642 9.55% | 118 709 -83.36% | -180 514 -135.04% | -67,0 358 -118.7% | -5 908 447 -1420.25% | 344 230 49.37% | -6,97 | 151 | 291 | 128 | 70,6 |
EPS USD | Released Forecast Spread | 0,33 0,67 -50.77% | -0,48 0,51 -194.77% | -4,31 0,88 -590.36% | 0,81 0,79 2.32% | 0,14 0,77 -81.76% | -0,21 0,52 -140.09% | -0,08 0,28 -128.63% | -6,85 0,35 -2067.49% | 0,40 0,23 73.7% | -0,05 | 0,14 | 0,28 | 0,16 | 0,11 |
Announcement Date | 30/06/22 | 13/10/22 | 05/01/23 | 28/03/23 | 27/06/23 | 12/10/23 | 04/01/24 | 28/03/24 | 27/06/24 | - | - | - | - | - |
Past sector events for Walgreens Boots Alliance, Inc.
04/07/2024 | WELCIA HOLDINGS CO., LTD.: Q1 2024 Earnings Release (Projected) |
27/06/2024 04:30 pm | WALGREENS BOOTS ALLIANCE, INC.: Q3 2024 Earnings Release |
20/06/2024 | SOPHARMA AD: May 2024 Sales and Revenue Release |
31/05/2024 10:35 am | DIS-CHEM PHARMACIES LIMITED: Q4 2024 Earnings Release |
30/05/2024 | SOPHARMA AD: Q1 2024 Earnings Release |
28/05/2024 04:21 pm | MEDPLUS HEALTH SERVICES LIMITED: Q4 2024 Earnings Release |
27/05/2024 | ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED: Q4 2024 Earnings Release |
20/05/2024 | SOPHARMA AD: April 2024 Sales and Revenue Release |
12/05/2024 10:32 am | SAUDI CHEMICAL HOLDING COMPANY: Q1 2024 Earnings Release |
10/05/2024 | MATSUKIYOCOCOKARA & CO.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- WBA Stock
- 0LSZ Stock
- Calendar Walgreens Boots Alliance, Inc.